Kymera Therapeutics, Inc. (KYMR)
131.73
+3.61
(+2.82%)
USD |
NASDAQ |
Nov 06, 16:00
131.70
-0.03
(-0.02%)
After-Hours: 20:00
Kymera Therapeutics Price : 131.73 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 129.41 | 132.68 | 126.65 | 131.73 | 786960.0 |
| Nov 05, 2026 | 137.54 | 138.00 | 124.22 | 128.12 | 1.729M |
| Nov 04, 2026 | 128.67 | 136.57 | 126.12 | 136.25 | 1.824M |
| Nov 03, 2026 | 128.79 | 133.88 | 126.48 | 127.09 | 1.402M |
| Nov 02, 2026 | 127.00 | 129.34 | 124.30 | 127.51 | 1.295M |
| Oct 30, 2026 | 122.58 | 127.26 | 117.31 | 126.63 | 1.592M |
| Oct 29, 2026 | 127.00 | 127.74 | 117.74 | 122.60 | 1.045M |
| Oct 28, 2026 | 116.17 | 122.91 | 115.46 | 122.51 | 768151.0 |
| Oct 27, 2026 | 114.52 | 119.68 | 111.14 | 117.57 | 828870.0 |
| Oct 26, 2026 | 111.96 | 115.22 | 110.31 | 114.84 | 438576.0 |
| Oct 23, 2026 | 110.85 | 111.82 | 109.05 | 110.76 | 517065.0 |
| Oct 22, 2026 | 111.43 | 113.74 | 110.13 | 110.85 | 850270.0 |
| Oct 21, 2026 | 113.38 | 115.75 | 112.52 | 112.63 | 1.056M |
| Oct 20, 2026 | 108.75 | 115.28 | 108.49 | 113.46 | 705158.0 |
| Oct 19, 2026 | 106.56 | 109.16 | 105.10 | 108.07 | 683373.0 |
| Oct 16, 2026 | 108.19 | 108.59 | 104.39 | 104.78 | 489328.0 |
| Oct 15, 2026 | 106.75 | 110.68 | 104.62 | 108.14 | 820992.0 |
| Oct 14, 2026 | 106.39 | 108.08 | 105.58 | 106.83 | 1.029M |
| Oct 13, 2026 | 110.83 | 112.06 | 106.52 | 106.68 | 779110.0 |
| Oct 12, 2026 | 111.61 | 113.13 | 110.52 | 112.08 | 537523.0 |
| Oct 09, 2026 | 109.54 | 115.82 | 107.46 | 112.40 | 1.305M |
| Oct 08, 2026 | 106.52 | 110.04 | 104.19 | 109.30 | 1.045M |
| Oct 07, 2026 | 104.58 | 108.68 | 103.45 | 108.35 | 1.167M |
| Oct 06, 2026 | 111.03 | 111.04 | 101.74 | 105.98 | 960714.0 |
| Oct 05, 2026 | 108.38 | 109.92 | 103.33 | 109.85 | 729726.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.35 |
| Twist Bioscience Corp. | 120.79 |
| Beam Therapeutics, Inc. | 26.41 |
| C4 Therapeutics, Inc. | 3.10 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
Price Related Metrics
| PS Ratio | 124.25 |
| PEG Ratio | -56.91 |
| Price to Book Value | 6.962 |
| Earnings Yield | -2.75% |
| Market Cap | 11.24B |
| PEGY Ratio | -56.91 |